Senti Biosciences

SNTINasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$11.016 M

$0.35 -1.45%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$61.4M

Loss-making

Shares outstanding

31,144,497

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#145Intensity TherapeuticsINTS$11.2M
#146BioCardiaBCDA$11.1M
#147Senti BiosciencesSNTI$11.0M
#148In8bioINAB$9.64M
#149Creative Medical TechnologyCELZ$9.36M

Where these numbers come from

Share counts and financials for Senti Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.